U.S. Move To Criminalise Doping...Except In Their Own Sports

U.S. Move To Criminalise Doping...Except In Their Own Sports
Gavin Cooney
By Gavin Cooney
Share this article

The latest from the U.S.: their lawmakers are moving toward criminalising international doping, but plan on exempting their own domestic sports from the ban.

The bill is entitled the Rodchenkov Anti-Doping Act (taking its name from Grigory Rodchenkov, the whistleblower on Russia's state-sponsored doping programme that rose to international prominence in the Netflix documentary, Icarus) and attaches prison time to the use, manufacturing or distribution of performance-enhancing drugs in global competitions.

Under the Act, the U.S. would have jurisdiction over any international competition which features at least three participating nations along with either at least four American athletes participating or two American companies acting as sponsors. These competitions would not have to be taking place in America. Proposed penalties for offenders would include a prison term of up to five years as well as fines that could stretch to $250,000 for individuals and $1 million for organizations.

Germany, France, Italy, Kenya and Spain are among the countries to make doping within their borders illegal, but the putative American bill goes much further.

Recommended

The sponsors of the bill justified such a reach by citing the American financial contribution to WADA which, at $2.3 million every year, is more substantial than any other contribution.

In spite of the extent of this bill, it does not apply to domestic American leagues like Major League Baseball and the NFL.

[NY Times]

Advertisement

See Also: LeBron James Played NBA Finals With Injury Picked Up In Farcical Circumstances

 

 

Join The Monday Club Have a tip or something brilliant you wanted to share on? We're looking for loyal Balls readers free-to-join members club where top tipsters can win prizes and Balls merchandise

Processing your request...

You are now subscribed!

Share this article

Copyright © 2024. All rights reserved. Developed by Square1 and powered by PublisherPlus.com

Advertisement